Investigational drug · Phase 3
NVG-291
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Chronic Spinal Cord Injury, Spinal Cord Injuries, Subacute Spinal Cord Injury.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
3
Any phase or sponsor naming "NVG-291"
First trial start
2023
Aug 8, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "NVG-291", any sponsor or status.
Conditions studied
As listed on its trial records.
- Chronic Spinal Cord Injury
- Spinal Cord Injuries
- Subacute Spinal Cord Injury
Largest trials
Live from ClinicalTrials.gov: studies naming "NVG-291" as an intervention, largest first.
- A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord InjuryPivotal-lookingRecruiting
NervGen PharmaIndustry
NCT07799532 · 150 participants (planned) · Start Sep 28, 2026 · Primary completion Jul 2027
Drug: NVG-291; Placebo · For: Chronic Spinal Cord Injury
Sites: Birmingham, Alabama; Pheonix, Arizona; Downey, California · 23 sites in all
NervGen PharmaIndustry
NCT05308953 · 74 participants · Start May 6, 2021 · Primary completion Jun 4, 2023
Drug: NVG-291 · For: Spinal Cord Injury
Sites: Melbourne, Australia
NervGen PharmaIndustry
NCT05965700 · 24 participants · Start Aug 8, 2023 · Primary completion Dec 31, 2025
Drug: NVG-291; Placebo Injection · For: Spinal Cord Injuries; Chronic Spinal Cord Injury; Subacute Spinal Cord Injury
Sites: Chicago, Illinois
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.